Khaled El Emam, SVP & GM, Replica Analytics
Khaled El Emam discusses accurate methods for measuring re-identification risk. This new class of risk estimators helps avoid issues experienced with many of the current risk measurement methods.
Measuring Re-identification Risk for Synthetic and Anonymized Data
RELATED ARTICLES
AdminMay 6, 20241 min read
Navigating the European Union's Medical Device Regulation (MDR)
On May 26, 2021 the European Union’s (EU) Medical Device Regulation (MDR) became effective. The MDR overhauls how the EU ...
Start Reading
Xi FangApr 20, 20241 min read
How to unleash the replicability potential of synthetic data
In today's data-driven world, the need for innovative solutions to evolve alongside the ever-challenging landscape of privacy ...
Start Reading
AdminApr 19, 2024< 1 min read
Case Study: Enhancing clinical trial data sharing with synthetic datasets
Unlock the future of research with our groundbreaking approach to privacy-preserving data sharing. Our case study, "Enhancing ...
Start Reading